within Pharmacolibrary.Drugs.ATC.C;

model C09AA07
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.37,
    Cl             = 5.5 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 10 / 1000000,
    adminCount     = 1,
    Vd             = 0.096,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.021666666666666667,
    Tlag           = 19.8
  );

  annotation(Documentation(
    info ="<html><body><p>Benazepril is an angiotensin-converting enzyme (ACE) inhibitor used primarily for the treatment of hypertension and congestive heart failure. It is approved and widely used in clinical practice today, both alone and in combination with other antihypertensive agents.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic data reported after single oral dose administration of benazepril in healthy adult volunteers.</p><h4>References</h4><ol><li><p>Gengo, FM, &amp; Brady, E (1991). The pharmacokinetics of benazepril relative to other ACE inhibitors. <i>Clinical cardiology</i> 14(8 Suppl 4) IV44–IV55. DOI:<a href=&quot;https://doi.org/10.1002/clc.4960141807&quot;>10.1002/clc.4960141807</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1893642/&quot;>https://pubmed.ncbi.nlm.nih.gov/1893642</a></p></li><li><p>King, JN, et al., &amp; Maurer, M (1999). Plasma angiotensin converting enzyme activity and pharmacokinetics of benazepril and benazeprilat in cats after single and repeated oral administration of benazepril.HCl. <i>Journal of veterinary pharmacology and therapeutics</i> 22(6) 360–367. DOI:<a href=&quot;https://doi.org/10.1046/j.1365-2885.1999.00230.x&quot;>10.1046/j.1365-2885.1999.00230.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/10651464/&quot;>https://pubmed.ncbi.nlm.nih.gov/10651464</a></p></li><li><p>Macdonald, NJ, et al., &amp; Elliott, HL (1993). The effects of age on the pharmacokinetics and pharmacodynamics of single oral doses of benazepril and enalapril. <i>British journal of clinical pharmacology</i> 36(3) 205–209. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1993.tb04218.x&quot;>10.1111/j.1365-2125.1993.tb04218.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9114905/&quot;>https://pubmed.ncbi.nlm.nih.gov/9114905</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C09AA07;
